Order Article Reprints

Zhu M, Taylor WR, Mahoney DW, Then SS, Berger CK, Burger KN, Gonser AM, Doering KA, Xie H, Foote PH, et al. Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies. Cancers. 2023; 15(24):5778. https://doi.org/10.3390/cancers15245778

Zhu, Mojun, William R. Taylor, Douglas W. Mahoney, Sara S. Then, Calise K. Berger, Kelli N. Burger, Anna M. Gonser, Karen A. Doering, Hao Xie, Patrick H. Foote, and et al. 2023. "Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies" Cancers 15, no. 24: 5778. https://doi.org/10.3390/cancers15245778

Zhu, M., Taylor, W. R., Mahoney, D. W., Then, S. S., Berger, C. K., Burger, K. N., Gonser, A. M., Doering, K. A., Xie, H., Foote, P. H., Kaiser, M. W., Allawi, H. T., Hubbard, J. M., & Kisiel, J. B. (2023). Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies. Cancers, 15(24), 5778. https://doi.org/10.3390/cancers15245778